1. Interaction with WDR5 promotes target gene recognition and tumorigenesis by MYC.
- Author
-
Thomas LR, Wang Q, Grieb BC, Phan J, Foshage AM, Sun Q, Olejniczak ET, Clark T, Dey S, Lorey S, Alicie B, Howard GC, Cawthon B, Ess KC, Eischen CM, Zhao Z, Fesik SW, and Tansey WP
- Subjects
- Amino Acid Motifs, Amino Acid Sequence, Animals, Anisotropy, Binding Sites genetics, Carcinogenesis genetics, Chromatin chemistry, Chromatin genetics, Fluorescence Polarization, HEK293 Cells, Humans, Intracellular Signaling Peptides and Proteins, Mice, Mice, Nude, Models, Molecular, Molecular Sequence Data, Mutation, NIH 3T3 Cells, Protein Binding, Protein Structure, Tertiary, Proteins chemistry, Proteins genetics, Proto-Oncogene Proteins c-myc chemistry, Proto-Oncogene Proteins c-myc genetics, Sequence Homology, Amino Acid, Two-Hybrid System Techniques, Carcinogenesis metabolism, Chromatin metabolism, Proteins metabolism, Proto-Oncogene Proteins c-myc metabolism
- Abstract
MYC is an oncoprotein transcription factor that is overexpressed in the majority of malignancies. The oncogenic potential of MYC stems from its ability to bind regulatory sequences in thousands of target genes, which depends on interaction of MYC with its obligate partner, MAX. Here, we show that broad association of MYC with chromatin also depends on interaction with the WD40-repeat protein WDR5. MYC binds WDR5 via an evolutionarily conserved "MYC box IIIb" motif that engages a shallow, hydrophobic cleft on the surface of WDR5. Structure-guided mutations in MYC that disrupt interaction with WDR5 attenuate binding of MYC at ∼80% of its chromosomal locations and disable its ability to promote induced pluripotent stem cell formation and drive tumorigenesis. Our data reveal WDR5 as a key determinant for MYC recruitment to chromatin and uncover a tractable target for the discovery of anticancer therapies against MYC-driven tumors., (Copyright © 2015 Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF